(RTTNews) - Gilead Sciences, Inc. (GILD) Monday reported positive topline results from the Phase 3 ASCENT-04/KEYNOTE-D19 study evaluating Trodelvy in combination with Merck's Keytruda in patients ...

(RTTNews) - Late-stage clinical biopharmaceutical company Sellas Life Sciences Group, Inc. (SLS) Tuesday announced positive survival in Cohort 3 data from the ongoing Phase 2 trial of SLS009 ...

Abstract: Dual three-phase permanent-magnet synchronous machines (DTP-PMSM) connected with a single neutral point provide a loop for zero-sequence current (ZSC). This paper proposes a novel space ...

TOKYO & BASKING RIDGE, N.J., March 31, 2025--(BUSINESS WIRE)--The first patient has been dosed in the DESTINY-Gastric05 phase 3 trial ... or metastatic HER2 positive (IHC 3+ or IHC 2+/ISH+ ...

Braintree ® intends to submit results from the TRIUMpH Phase 3 studies to a high impact, peer reviewed journal along with presentation of this data at a leading gastroenterology conference in the ...

Braintree Laboratories, a part of Sebela Pharmaceuticals and a leading manufacturer of gastroenterology pharmaceutical products, announced positive topline results from two pivotal US phase 3 clinical ...

LEVI-04, a Novel Neurotrophin-3 Inhibitor, Substantially Improves Pain and Function in People with Knee Osteoarthritis: a Randomised Controlled Phase II Trial. Authors: Conaghan, Philip G; Guermazi, ...

and pancreatic ductal adenocarcinoma (PDAC), as well as a positive pivotal randomized, placebo-controlled phase 3 clinical trial of CAN-2409 in localized, non-metastatic prostate cancer. In December ...

Gilead Sciences said that it saw positive results from the phase 3 study of its Trodelvy therapy in combination with Merck's Keytruda in patients with inoperable locally advanced or metastatic ...